Filing Flows

Filing Flows › GE HealthCare Technologies (GEHC) › Guidance history

GE HealthCare Technologies (GEHC) guidance history: what it guided and what it reported

GE HealthCare Technologies gave guidance in 12 earnings releases on file since Feb 6, 2024. Its releases raised guidance 4 times and lowered it 4 times.

Adjusted operating margin

The guide is on an adjusted basis that the GAAP statements do not show, so there is no reported figure to hold it to.

PeriodGuided (and how it moved)ReportedResultvs midpoint
FY202615.8%–16.1% (Feb 4, 2026) → lowered 15.4%–15.7% (Apr 29, 2026) → reaffirmed 15.4%–15.7% (Jul 29, 2026) → lowered 15.3% (Oct 28, 2026)—to be reported—
FY202516.7%–16.8% (Feb 13, 2025) → lowered 14.2%–14.4% (Apr 30, 2025) → raised 15.2%–15.4% (Jul 30, 2025) → reaffirmed 15.2%–15.4% (Oct 29, 2025)———
FY202415.6%–15.9% (Feb 6, 2024) → reaffirmed 15.6%–15.9% (Apr 30, 2024) → lowered 15.1% (Jul 31, 2024) → reaffirmed 15.1% (Oct 30, 2024)———

Adjusted tax rate

The guide is on an adjusted basis that the GAAP statements do not show, so there is no reported figure to hold it to.

PeriodGuided (and how it moved)ReportedResultvs midpoint
FY202620.0%–21.0% (Feb 4, 2026) → reaffirmed 20.0%–21.0% (Apr 29, 2026) → reaffirmed 20.0%–21.0% (Jul 29, 2026)—to be reported—
FY202522.0%–23.0% (Feb 13, 2025) → lowered 21.0%–22.0% (Apr 30, 2025) → lowered 20.0%–21.0% (Jul 30, 2025) → reaffirmed 20.0%–21.0% (Oct 29, 2025)———
FY202423.0%–25.0% (Feb 6, 2024) → reaffirmed 23.0%–25.0% (Apr 30, 2024) → reaffirmed 23.0%–25.0% (Jul 31, 2024)———

Free cash flow

The GAAP figure from the filings is shown for each period reported; it is not judged against the guide, which may leave items out (one-off payments, acquisitions).

PeriodGuided (and how it moved)ReportedResultvs midpoint
FY2026$1.5B (Feb 4, 2026) → raised $1.6B (Apr 29, 2026) → reaffirmed $1.6B (Jul 29, 2026) → lowered $1.5B (Oct 28, 2026)—to be reported—
FY2025$1.8B (Feb 13, 2025) → lowered $1.2B (Apr 30, 2025) → raised $1.4B (Jul 30, 2025) → reaffirmed $1.4B (Oct 29, 2025)$1.5B (GAAP)not judged—
FY2024$1.8B (Feb 6, 2024) → reaffirmed $1.8B (Apr 30, 2024) → reaffirmed $1.8B (Jul 31, 2024) → reaffirmed $1.8B (Oct 30, 2024)$1.6B (GAAP)not judged—

EPS

Every guided period is still to be reported.

PeriodGuided (and how it moved)ReportedResultvs midpoint
FY2026$4.59 (Oct 28, 2026)—to be reported—

Adjusted EPS

The guide is on an adjusted basis that the GAAP statements do not show, so there is no reported figure to hold it to.

PeriodGuided (and how it moved)ReportedResultvs midpoint
FY2026$4.95–$5.15 (Feb 4, 2026) → lowered $4.80–$5.00 (Apr 29, 2026) → reaffirmed $4.80–$5.00 (Jul 29, 2026)—to be reported—
FY2025$4.61–$4.75 (Feb 13, 2025) → lowered $3.90–$4.10 (Apr 30, 2025) → raised $4.43–$4.63 (Jul 30, 2025) → raised $4.51–$4.63 (Oct 29, 2025)———
FY2024$4.20–$4.35 (Feb 6, 2024) → reaffirmed $4.20–$4.35 (Apr 30, 2024) → reaffirmed $4.20–$4.35 (Jul 31, 2024) → raised $4.25–$4.35 (Oct 30, 2024)———

The latest quarter

GE HealthCare Technologies, Q3 2026: revenue $5.5B (+7% year over year), operating margin 14.6%, net earnings $615M, operating cash flow $907M. The chart follows the revenue to costs, profit and cash.

Questions

Does GE HealthCare Technologies beat its guidance?

GE HealthCare Technologies gave guidance in 12 earnings releases on file since Feb 6, 2024. Its releases raised guidance 4 times and lowered it 4 times.

How often does GE HealthCare Technologies raise guidance?

Its earnings releases raised guidance 4 times and lowered it 4 times since Feb 6, 2024.

Latest guidance and outlook →

Each guided period is held to the last guidance given before its figures were reported; a single figure counts as in line within 1% (0.25 pts for a rate). Reported figures are GAAP, from the company's filings; adjusted guidance shows its moves only.